ChEMBL is a public database of bioactive drug-like small molecules, it contains 2-D structures, calculated properties (e.g. logP, Molecular Weight, Lipinski Parameters, etc.) and abstracted bioactivities (e.g. binding constants, pharmacology and ADMET data). The data is abstracted and curated from the primary scientific literature, and covers a significant fraction of the SAR and discovery of modern drugs. 
The ChEMBL-og – The news (including FDA new drug approvals), progress, whereabouts, and ephemera from the Computational Chemical Biology group at the EMBL-EBI.

ChEMBL Road Show:

In April 2013 the ChEMBL Road Show visited 14 universities around the UK and raised the profile of both ChEMBL and amongst academic researchers. The presentation showcased to chemists and life scientists how ChEMBL and can improve research outcomes and facilitate interdisciplinary collaborations. Audience feedback recognised the potential of ChEMBL to enhance research output, and offered suggestions for additional features to be included. Two universities plan to add ChEMBL to their postgraduate training set, which is a fantastic result.

A second tour will take place in May / June 2014 visiting universities in mainland Europe.